Yorkshire Retina Society Winter
Meeting
|
We are pleased to bring you a full day meeting hosted by
the York team.
The next Yorkshire Retina Society meeting is to held at
the Principal Hotel, York for a full day on Friday 8th
December 2023. You can find venue directions below.
Registration is now open - Please complete
registration form here.
Once you have registered
for the meeting, please use the PayPal button below to
purchase your attendance.
The name of the meeting will be Updates in the Management
of Macular Degeneration and Uveitis, and the agenda for
the day is as follows:
9.00
Registration and Coffee
9.25
Welcome note. Meeting Chair Richard Gale
Symposium:
New therapies for nAMD
Chair
Miss Nicola Topping
9.30
Is
16 weeks dosing the new expectation in AMD? Experience
with emerging therapies. Dr David Brown, Retinal
Consultants of Texas.
David
Brown’s attendance has been supported through Bayer
sponsorship of the YRS meeting. Bayer has had no input
to the content of Dr Brown’s presentation.
9.55
‘Anatomical
Endpoints with Dual Inhibition: How important are
they'? #
Dr
Dilsher Dhoot, California Retina Consultant.
Roche
Products Limited has provided financial support for
this meeting but has had no involvement in the agenda
other than this organised presentation. This is a
promotional session and will include discussions about
Roche products.
10.20
Discussion
Debate
1: addressing unmet needs in nAMD. Chair:
Mrs Archana Airody
Time for a co-ordinated screening
programme for nAMD in the UK
10.35
Yes.
Richard Gale, York
10.45
No. Peter Scanlon, Oxford
10.55
Discussion
Coffee
Debate 2:
A virtual service should be the mainstay of managing
patients with AMD.
11.35
Yes. Louise Downey, Hull
11.45
No Tariq Aslam, Manchester
11.55
Discussion
12.05
Lecture: Automated detection of treatable Macular
Disease in the community; is it coming soon Pearse
Keane, Moorfields Eye Hospital
12.25
Discussion
12:30
Lunch and Exhibition
Symposium:
Update in the Management of Uveitis Chair:
Greg Heath
13.30
Assessing
Endpoints in Uveitis: measuring what matters: Nick Beare
13.45
Discussion:
13.55
Emerging therapies in Uveitis : treating what matters: Nick Beare
14.05
Discussion
Case
presentations: Contemporary AMD or Uveitis Cases
Chair : Divya Venogopal TBC
(7 min presentations, 3 min questions)
14.15
– Presentations
Debate 3:
Complement inhibition therapies for Geographic Atrophy
will be a paradigm shift.
14.45
Yes, Ian Pearce, Liverpool
14.55
No, James Talks, Newcastle
15.05
Discussion
Coffee
Keynote
presentations Chair:
Richard Gale
15.45
Which Cell and Gene therapies will be in clinical
practice within 5 years?
Dilsher
Dhoot, California Retina Consultants
16.05
Managing side effects of emerging therapies for AMD.
David Brown
16.25
Discussion ‘Ask the experts’.
16.45
Summary and close.
Meeting Venue
and Directions
Registration
Please
complete registration form here.
If
you would prefer to pay via BACS, please email
admin@yorkshireretinasociety.com.
Evaluation - Will be available after the meeting.
Attendance Certificate - will be available after
the meeting.
|